- Status:
- In progress
- Technology type:
- Medicine
- Decision:
- Selected
- Prioritisation programme:
- Medicines evaluation
- Rationale:
Review of TA972.
- Process:
- STA Standard
- ID number:
- 6757
Provisional Schedule
- Committee meeting:
- 13 January 2027
- Expected publication:
- 13 May 2027
Project Team
- Project lead
- Kate Moore
Email enquiries
If you have any queries please email TACommD@nice.org.uk
- External Assessment Group:
- Kleijnen Systematic Reviews Ltd
Stakeholders
- Companies sponsors
- Plusultra (sirolimus gel)
- Others
- Department of Health and Social Care
- NHS England
- Patient carer groups
- Beacon for Rare Diseases
- Changing Faces
- Gene People
- Genetic Alliance UK
- Let’s Face It
- South Asian Health Foundation
- Specialised Healthcare Alliance
- Tuberous Sclerosis Association
- Professional groups
- Association of Genetic Nurses & Counsellors
- British Association of Dermatologists
- British Dermatological Nursing Group
- British Geriatrics Society
- British Society for Gene and Cell Therapy
- British Society for Genetic Medicine
- British Society for Paediatric and Adolescent Dermatology
- General Medical Council
- Neonatal and Paediatric Pharmacists Group
- Primary Care Dermatology Society
- Psychodermatology UK
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Paediatrics and Child Health
- Royal College of Pathologists
- Royal College of Physicians
- Royal Pharmaceutical Society
- Royal Society of Medicine
- UK Clinical Pharmacy Association
- UK Kidney Association
- Associated public health groups
- Public Health Wales
- UK Health Security Agency
- Comparator companies
- None
- General commentators
- All Wales Therapeutics and Toxicology Centre
- Allied Health Professionals Federation
- Board of Community Health Councils in Wales
- British National Formulary
- Care Quality Commission
- Cell and Gene Therapy Catapult
- Department of Health - Northern Ireland
- Great Ormond Street Hospital
- Healthcare Improvement Scotland
- Medicines and Healthcare products Regulatory Agency
- National Association of Primary Care
- National Pharmacy Association
- NHS Confederation
- NHS Wales Joint Commissioning Committee
- Scottish Medicines Consortium
- Welsh Government
- Relevant research groups
- British Skin Foundation
- Cochrane Skin Group
- Dermatrust
- Genomics England
- MRC Clinical Trials Unit
- National Institute for Health Research
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 10 June 2026 | Invitation to participate |
| 10 June 2026 | Awaiting development. Status change linked to topic prioritisation decision being set to Selected |
| 10 June 2026 | In progress. Invitation to participate |
| 06 May 2026 - 27 May 2026 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual